Asset Management One Co., Ltd. Bristol Myers Squibb CO Transaction History

Asset Management One Co., Ltd.

$25.9 Billion
Q2 2024

A detailed history of Asset Management One Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 925,825 shares of BMY stock, worth $49.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

925,825

Previous 971,426 4.69%

Holding current value

$49.2 Million

Previous $52.7 Million 27.01%

% of portfolio

0.15%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$40.25 - $52.99 $1.84 Million - $2.42 Million	-45,601 Reduced 4.69%	925,825 $38.4 Million
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $3.08 Million - $3.49 Million	-64,161 Reduced 6.2%	971,426 $52.7 Million
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $3.98 Million - $4.75 Million	-82,118 Reduced 7.35%	1,035,587 $53.1 Million
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $3.13 Million - $3.5 Million	-54,023 Reduced 4.61%	1,117,705 $64.9 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $2.07 Million - $2.3 Million	-32,479 Reduced 2.7%	1,171,728 $74.9 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $797,719 - $904,794	12,140 Added 1.02%	1,204,207 $83.5 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $4.46 Million - $5.28 Million	65,127 Added 5.78%	1,192,067 $85.8 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $322 - $190,716	-2,482 Reduced 0.22%	1,126,940 $80.1 Million
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $2.03 Million - $2.23 Million	-27,904 Reduced 2.41%	1,129,422 $87 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $168,332 - $201,845	2,738 Added 0.24%	1,157,326 $84.5 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $861,994 - $1 Million	-16,073 Reduced 1.37%	1,154,588 $71.9 Million
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $1.18 Million - $1.38 Million	-19,977 Reduced 1.68%	1,170,661 $69.3 Million
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $1.9 Million - $2.07 Million	-30,630 Reduced 2.51%	1,190,638 $79.6 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $2.14 Million - $2.41 Million	-36,040 Reduced 2.87%	1,221,268 $77.1 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.88 Million - $2.13 Million	32,515 Added 2.65%	1,257,308 $77.3 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1.57 Million - $1.74 Million	-27,372 Reduced 2.19%	1,224,793 $73.8 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $4.63 Million - $5.41 Million	-84,408 Reduced 6.32%	1,252,165 $73.6 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $550,489 - $799,989	11,864 Added 0.9%	1,336,573 $74.5 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $18.9 Million - $24.6 Million	383,715 Added 40.78%	1,324,709 $85 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $658,529 - $780,781	15,397 Added 1.66%	940,994 $47.7 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $375,968 - $415,738	-8,426 Reduced 0.9%	925,597 $42 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $81 Million - $96.6 Million	-1,795,762 Reduced 65.78%	934,023 $44.6 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $2.41 Million - $3.13 Million	49,462 Added 1.85%	2,729,785 $142 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $664,211 - $749,178	12,035 Added 0.45%	2,680,323 $166 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.94 Million - $2.42 Million	38,457 Added 1.46%	2,668,288 $148 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $518,547 - $596,952	8,654 Added 0.33%	2,629,831 $166 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $248,631 - $271,071	-4,148 Reduced 0.16%	2,621,177 $161 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $394,839 - $455,677	-7,149 Reduced 0.27%	2,625,325 $167 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,632,474	2,632,474 $147 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Bristol Myers Squibb CO Transaction History